Original Research

Published on 07 Aug 2024

CKD-497 inhibits NF-kB signaling and ameliorates inflammation and pulmonary fibrosis in ovalbumin-induced asthma and particulate matter-induced airway inflammatory diseases

in Respiratory Pharmacology

Hyejeong Kim
Jihye Choi
Jaeok Seo
Hyungjoon Lim
Sung Kwon Kang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428567

1,289 views

Review

Published on 23 Jul 2024

Role and regulators of N6-methyladenosine (m6A) RNA methylation in inflammatory subtypes of asthma: a comprehensive review

in Respiratory Pharmacology

Ge Gao
Yu Qiu Hao
Chen Wang
Peng Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360607

1,117 views

Original Research

Published on 18 Jul 2024

Effect of different sedatives on the prognosis of patients with mechanical ventilation: a retrospective cohort study based on MIMIC-IV database

in Respiratory Pharmacology

Xiaoding Shi
Jiaxing Zhang
Yufei Sun
Meijun Chen
Fei Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1301451

1,937 views

Original Research

Published on 18 Jul 2024

Exploring the associations between elevated plasma SP-D levels and OSCAR gene expression as potential biomarkers in patients with COPD: a cross-sectional study

in Respiratory Pharmacology

Saima Mukhtar
Nakhshab Choudhry
Saqib Saeed
Asif Hanif
Aamir J. Gondal
Nighat Yasmin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376394

963 views

Editorial

Published on 09 Jul 2024

Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery

in Respiratory Pharmacology

Poonam Arora
Lalit Mohan Nainwal
Seyyed Shamsadin Athari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419138

615 views

Methods

Published on 01 Jul 2024

A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency

in Respiratory Pharmacology

Celine H. Chen
Helena Crisford
Aaron Scott
Elizabeth Sapey
Robert A. Stockley

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1421598

1,060 views

Original Research

Published on 24 Jun 2024

Tropine exacerbates the ventilatory depressant actions of fentanyl in freely-moving rats

in Respiratory Pharmacology

Paulina M. Getsy
Walter J. May
Alex P. Young
Santhosh M. Baby
Gregory A. Coffee
James N. Bates
Yee-Hsee Hsieh
Stephen J. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405461

763 views

Case Report

Published on 04 Jun 2024

Case report: EGFR-TKI rechallenge after osimertinib-induced interstitial lung disease: a case report and literature review

in Respiratory Pharmacology

Xiaofei Gu
Yonghong Zhong
Huaqiong Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410684

1,349 views
1 citation

Correction

Published on 28 May 2024

Corrigendum: Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats

in Respiratory Pharmacology

Nicole Reyne
Patricia Cmielewski
Alexandra McCarron
Ronan Smith
Elena Schneider-Futschik
Nina Eikelis
Piraveen Pirakalathanan
David Parsons
Martin Donnelley

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428213

570 views

Clinical Trial

Published on 10 May 2024

The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study

in Respiratory Pharmacology

Ling Zhou
Yan Deng
Kui Liu
Huiguo Liu
Wei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380939

1,566 views

Original Research

Published on 10 May 2024

Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma

in Respiratory Pharmacology

Xiaoyue Zeng
Lu Xue
Wei Li
Ping Zhao
Weiwei Chen
Wenyi Wang
Jinhua Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345070

1,198 views

Original Research

Published on 09 May 2024

Vitamin D level in COVID-19 patients has positive correlations with autophagy and negative correlations with disease severity

in Respiratory Pharmacology

Hongna Dong
Yuqiu Hao
Peng Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388348

1,325 views

Original Research

Published on 07 May 2024

Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma–COPD (ACO) model

in Respiratory Pharmacology

Juliana Morelli Lopes Gonçalves João
Jéssica Anastácia Silva Barbosa
Luana Laura Sales da Silva
Silvia Fukuzaki
Elaine Cristina de Campos
Leandro do Nascimento Camargo
Tabata Maruyama dos Santos
Suellen Karoline Moreira Bezerra
Francine Maria de Almeida
Beatriz Mangueira Saraiva-Romanholo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1282870

1,484 views
1 citation

Editorial

Published on 25 Apr 2024

Editorial: Pathogen targeting in chronic respiratory diseases: prevention, therapy and management

in Respiratory Pharmacology

Shakti D. Shukla
Kamal Dua
Ronan F. O’Toole

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407616

632 views

Original Research

Published on 18 Apr 2024

Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing

in Respiratory Pharmacology

Santhosh M. Baby
Walter J. May
Paulina M. Getsy
Gregory A. Coffee
Tej Nakashe
James N. Bates
Alan Levine
Stephen J. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381073

1,722 views
1 citation

Review

Published on 27 Mar 2024

Functional roles of circular RNAs in lung injury

in Respiratory Pharmacology

Fei-Fei Gao
Dian-Qing Chen
Yue-Tong Jiang
Cui-Fei Han
Bi-Yun Lin
Zhan Yang
Juan-Hua Quan
Ying-Huan Xiong
Xin-Tian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1354806

1,417 views

Navigation group

Articles

CKD-497 inhibits NF-kB signaling and ameliorates inflammation and pulmonary fibrosis in ovalbumin-induced asthma and particulate matter-induced airway inflammatory diseases

Role and regulators of N6-methyladenosine (m6A) RNA methylation in inflammatory subtypes of asthma: a comprehensive review

Effect of different sedatives on the prognosis of patients with mechanical ventilation: a retrospective cohort study based on MIMIC-IV database

Exploring the associations between elevated plasma SP-D levels and OSCAR gene expression as potential biomarkers in patients with COPD: a cross-sectional study

Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery

A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency

Tropine exacerbates the ventilatory depressant actions of fentanyl in freely-moving rats

Case report: EGFR-TKI rechallenge after osimertinib-induced interstitial lung disease: a case report and literature review

Corrigendum: Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats

The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study

Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma

Vitamin D level in COVID-19 patients has positive correlations with autophagy and negative correlations with disease severity

Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma–COPD (ACO) model

Editorial: Pathogen targeting in chronic respiratory diseases: prevention, therapy and management

Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing

Functional roles of circular RNAs in lung injury